Le Lézard
Classified in: Health
Subjects: AWD, NPT, TDS, FVT

Leaders and Innovators in Medical and Surgical Eye Care Honored by the American Academy of Ophthalmology



NEW ORLEANS, Nov. 10, 2017 /PRNewswire-USNewswire/ -- The American Academy of Ophthalmology is honoring ophthalmologists who have improved eye care for millions worldwide through their commitment to their patients and their profession. The honorees will be recognized during AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.

AAO Logo (PRNewsFoto/American Academy of Ophthalmology)

The most prestigious of these honors is the Laureate Recognition Award. It recognizes an individual who has made exceptional scientific contributions to the betterment of eye care, leading to the prevention of blindness and restoration of sight worldwide.

This year's honoree is Irene H. Maumenee, M.D., a world-renowned leader in inherited eye disease whose seminal work led to the creation of ophthalmic genetics as a subspecialty in the United States. Dr. Maumenee's insights have contributed significantly to the development of the first effective gene therapy for inherited retinal disease.

In 1977, Dr. Maumenee began the Ophthalmic Genetics Study Club, which later became known as the International Society for Genetic Eye Diseases and Retinoblastoma. While at The Johns Hopkins Wilmer Eye Institute in Baltimore, Dr. Maumenee founded and directed the Johns Hopkins Center for Hereditary Eye Diseases, an international referral program that has evaluated, diagnosed, and treated more than 30,000 patients with rare eye diseases. More recently, she helped establish an ophthalmic genetics center at the University of Illinois Eye and Ear Infirmary in Chicago.

"I am thrilled to recognize Dr. Maumenee for her years of outstanding leadership and innovation in eye care," said David W. Parke II, M.D., CEO of the American Academy of Ophthalmology. "She has played an important and vital role in our efforts to protect sight and empower lives; all while preparing future generations of eye physicians and surgeons to become thought leaders within the field of ophthalmology."

Other awards presented during AAO 2017 include:

"This year's award winners' dedication and innovative work in the field of medicine has been essential to driving ophthalmology forward," Dr. Bradford said. "Their exceptional achievements in service and education have advanced our ability to solve challenging problems, all while ensuring that patients receive the effective care they need."

For full awards descriptions, recipient biographies and information about additional awards presented to Academy members at AAO 2017, please visit www.aao.org/awards. The Academy's annual meeting ? "Where all of Ophthalmology Meetstm" ? takes place Nov. 11 ? 14, 2017, at the Ernest N. Morial Convention Center in New Orleans. It is the largest ophthalmology conference in the world.

About the American Academy of Ophthalmology
The American Academy of Ophthalmology is the world's largest association of eye physicians and surgeons. A global community of 32,000 medical doctors, we protect sight and empower lives by setting the standards for ophthalmic education and advocating for our patients and the public. We innovate to advance our profession and to ensure the delivery of the highest-quality eye care. Our EyeSmart® program provides the public with the most trusted information about eye health. For more information, visit aao.org.

 

SOURCE American Academy of Ophthalmology


These press releases may also interest you

at 02:00
SACRAMENTO, Calif., Sept. 22, 2018 /PRNewswire-PRWeb/ -- The health risks associated with heart disease, stroke, and cancer are well-known. Less well-known, however, is the serious health risk that particularly affects older adults ? the risk of...

21 sep 2018
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 22, 2018 to file lead plaintiff applications in a securities class action lawsuit against Nevro Corp. , if they purchased the Company's shares between...

21 sep 2018
ROCKVILLE, Md., Sept. 21, 2018 /PRNewswire-PRWeb/ -- - Bharti Shah, Chief Executive Officer CTIS, Inc., Rockville, MD based Health Informatics company, today announced the promotion of Ms. Bharti Shah to Chief Executive Officer. She will have the...

21 sep 2018
Pharmaceutical startup Bridge Therapeutics announces the addition of Dr. Bob Raffa as its newest Scientific Advisory Board member. "We are delighted to have Dr. Raffa join our scientific advisory board. His research on pain and addiction medications...

21 sep 2018
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from a Phase 3 clinical study of the investigational product esketamine nasal spray in patients with treatment-resistant depression. Janssen researchers presented these...

21 sep 2018
The "Global Burkitt Lymphoma Therapeutics Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The Global Burkitt Lymphoma Market to grow at a CAGR of 3.07% during the period 2018-2022. Burkitt lymphoma market 2018-2022,...




News published on 10 november 2017 at 13:57 and distributed by: